In addition, A combination of radiotherapy with anti-CEACAM1 immunotherapy significantly inhibited the proliferation of murine intracranial glioma, extended the survival time of mice, and even restored anti-tumour immunity in some mice. The gene discussed is CEACAM1; the disease is neoplasm.